Insights

Innovative Bio-Products Cardium Therapeutics specializes in developing therapeutic products for wound healing, bone repair, and cardiovascular conditions, indicating potential demand for advanced medical devices and biologics in these high-growth segments.

Strategic Portfolio Focus The company's portfolio includes assets like Tissue Repair and Cardium Biologics, suggesting opportunities for partnerships or acquisitions in innovative biotech solutions targeting unmet medical needs.

Recent Asset Monetization The sale of InnerCool Therapies to Royal Philips demonstrates Cardium's strategy of asset monetization, providing a possible pathway for revenue generation through commercial sales or licensing of its remaining technologies.

Growth Potential With revenue estimates between 1 million and 10 million dollars and ongoing clinical studies like the Matrix Phase 2b, Cardium presents opportunities for early-stage investment and collaborations to accelerate product commercialization.

Technology and Digital Presence Utilizing modern web technologies such as WordPress and Google Analytics indicates an active digital engagement strategy, useful for identifying direct sales channels and outreach opportunities within the biotech community.

Cardium Therapeutics, Inc. Tech Stack

Cardium Therapeutics, Inc. uses 8 technology products and services including WordPress, Font Awesome, Google Fonts API, and more. Explore Cardium Therapeutics, Inc.'s tech stack below.

WordPress

Content Management System

Font Awesome

Font Scripts

Google Fonts API

Font Scripts

yepnope.js

Javascript Frameworks

TweenMax

Javascript Frameworks

jQuery

Javascript Libraries

Google Analytics

Web Analytics

prettyPhoto

Web Tools And Plugins

Cardium Therapeutics, Inc. Email Formats	Example	Percentage
FLast@cardiumthx.com	JDoe@cardiumthx.com	92%
First.Last@cardiumthx.com	John.Doe@cardiumthx.com	8%

Cardium Therapeutics, Inc. Email Formats

Example

Percentage

FLast@cardiumthx.com

JDoe@cardiumthx.com

92%

First.Last@cardiumthx.com

John.Doe@cardiumthx.com

Frequently Asked Questions

Where is Cardium Therapeutics, Inc.'s headquarters located?

Cardium Therapeutics, Inc.'s main headquarters is located at 12255 el Camino Real Suite 250 San Diego, California 92130 United States. The company has employees across 1 continents, including North America.

What is Cardium Therapeutics, Inc.'s phone number?

You can contact Cardium Therapeutics, Inc.'s main corporate office by phone at

+1-858-436-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cardium Therapeutics, Inc.'s official website and social media links?

Cardium Therapeutics, Inc.'s official website is cardiumthx.com and has social profiles on LinkedIn Crunchbase.

What is Cardium Therapeutics, Inc.'s SIC code NAICS code?

Cardium Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cardium Therapeutics, Inc. have currently?

As of April 2026, Cardium Therapeutics, Inc. has approximately 7 employees across 1 continents, including North America. Key team members include Chief Scientific Officer: G. R.Vp Biologics Development: B. S.Vice President Biologics Development: L. A. C.. Explore Cardium Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Cardium Therapeutics, Inc. belong to?

Cardium Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Cardium Therapeutics, Inc. use?

Cardium Therapeutics, Inc.'s tech stack includes WordPressFont AwesomeGoogle Fonts APIyepnope.jsTweenMaxjQueryGoogle AnalyticsprettyPhoto.

What is Cardium Therapeutics, Inc.'s email format?

Cardium Therapeutics, Inc.'s email format typically follows the pattern of FLast@cardiumthx.com. Find more Cardium Therapeutics, Inc. email formats with LeadIQ.

How much funding has Cardium Therapeutics, Inc. raised to date?

As of April 2026, Cardium Therapeutics, Inc. has raised $750K in funding. The last funding round occurred on Jun 11, 2009 for $750K.

Cardium Therapeutics, Inc.

Q: How many employees does Cardium Therapeutics, Inc. have currently?

Cardium Therapeutics, Inc. has approximately 7 employees.

Q: What technology does Cardium Therapeutics, Inc. use?

Cardium Therapeutics, Inc.'s tech stack includes PHP, jQuery Migrate, Modernizr, WordPress, Google Analytics.

Q: What is Cardium Therapeutics, Inc.'s NAICS code?

Cardium Therapeutics, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchCalifornia, United States2-10 Employees

Cardium Therapeutics is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, partnering and other economic monetizations.  Cardium’s investment portfolio includes the Tissue Repair Company and Cardium Biologics, medical technology companies primarily focused on the development of innovative therapeutic products for wound healing, bone repair, and cardiovascular indications.  In May 2009, Cardium announced completion of the enrollment for the Matrix Phase 2b clinical study to evaluate the Excellarate product candidate as a treatment for patients with non-healing diabetic ulcers.  In July 2009, Cardium completed the sale of its InnerCool Therapies medical device business to Royal Philips Electronics, the first asset monetization from the Company’s biomedical investment portfolio.

Insights

Similar companies to Cardium Therapeutics, Inc.

Amarin Corporation

Ligand Pharmaceuticals

Incyte

Vertex Pharmaceuticals

Biogen

Gilead Sciences

Amgen